Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-κB ligand

Infection and Immunity

Volumn 71, Issue 10, 2003, Pages 6019-6026

  Sakurai, Atsuo ^a   Okahashi, Nobuo ^a   Nakagawa, Ichiro ^a   Kawabata, Shigetada ^a,b   Amano, Atsuo ^a   Ooshima, Takashi ^a   Hamada, Shigeyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BETA HEMOLYTIC STREPTOCOCCUS; BONE DESTRUCTION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INFECTIOUS ARTHRITIS; MOUSE; MOUSE STRAIN; NEISSERIA GONORRHOEAE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; STAINING; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES;

ANIMALS; ARTHRITIS, INFECTIOUS; BONE RESORPTION; CARRIER PROTEINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MICE; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 0141446041     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.10.6019-6026.2003     Document Type: Article

References (37)

1. Alkan, M., I. Ofek, and E. H. Beachey. 1977. Adherence of pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect. Immun. 18:555-557.
2. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsco, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
3. Ayoub, E. M., and H. A. Majeed. 2000. Poststreptococcal reactive arthritis. Curr. Opin. Rheumatol. 12:306-310.
4. Badolato, R., and J. J. Oppenheim. 1996. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin. Arthritis Rheum. 26:526-538.
5. Bremell, T., S. Lange, A. Yacoub, C. Rydén, and A. Tarkowski. 1991. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 59:2615-2623.
6. Cromartie, W. J., J. G. Craddock, J. H. Schwab, S. K. Anderle, and C. H. Yang. 1977. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J. Exp. Med. 146:1585-1602.
7. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
8. Fata, J. E., Y. Y. Kong, J. Li, T. Sasaki, J. Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, R. Khokha, and J. M. Penninger. 2000. The osteoclast differentiation factor osteoprotegerin ligand is essential for mammary gland development. Cell 103:41-50.
9. Gerard, H. C., Z. Wang, G. F. Wang, H. El-Gabalawy, R. Goldbach-Mansky, Y. Li, W. Majeed, H. Zhang, N. Ngai, A. P. Hudson, and H. R. Schumacher. 2001. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum. 44:1689-1697.
10. Goldenberg, D. L. 1998. Septic arthritis. Lancet 351:197-207.
11. Horowitz, M. C., Y. Xi, K. Wilson, and M. A. Kacena. 2001. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 12:9-18.
12. Hultgren, O., H. P. Eugster, J. D. Sedgwick, H. Korner, and A. Tarkowski. 1998. TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J. Immunol. 161:5937-5942.
13. Jadoun, J., V. Ozeri, E. Burstein, E. Skutelsky, E. Hanski, and S. Sela. 1998. Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J. Infect. Dis. 178:147-158.
14. Kawabata, S., H. Kuwata, I. Nakagawa, S. Morimatsu, K. Sano, and S. Hamada. 1999. Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microb. Pathog. 27:71-80.
15. Koga, T., K. Kakimoto, T. Hirofuji, S. Kotani, H. Ohkuni, K. Watanabe, N. Okada, H. Okada, A. Sumiyoshi, and K. Saisho. 1985. Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria. Infect. Immun. 50:27-34.
16. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, T. Wong, G. Campanguolo, E. Moran, E. R. Bogoch, G. Van, L. T. Nguyen, P. S. Ohashi, D. L. Lacey, E. Fish, W. J. Boyle, and J. M. Penninger. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309.
17. Kong, Y. Y., H. Yoshida, I. Sarosi, H. I. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
18. Kotake, S., N. Udagawa, M. Hakoda, M. Mogi, K. Yano, E. Tsuda, K. Takahashi, T. Furuya, S. Ishiyama, K.-J. Kim, S. Saito, T. Nishikawa, N. Takahashi, A. Togari, T. Tomatsu, T. Suda, and N. Kamatani. 2001. Activated human T cells directly induce osteoclastogenesis from human monocytes. Arthritis Rheum. 44:1003-1012.
19. Molinari, G., and G. S. Chhatwal. 1999. Streptococcal invasion. Curr. Opin. Microbiol. 2:56-61.
20. Moon, R. Y., M. G. Greene, G. T. Rehe, and I. M. Katona. 1995. Poststreptococcal reactive arthritis in children: a potential predecessor of rheumatic heart disease. J. Rheumatol. 22:529-532.
21. Nakagawa, I., M. Nakata, S. Kawabata, and S. Hamada. 2001. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes-infected epithelial cells. Cell. Microbiol. 3:395-405.
22. Neeman, R., N. Keller, A. Barzilai, Z. Korenman, and S. Sela. 1998. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974-1977.
23. Okahashi, N., A. Sakurai, I. Nakagawa, T. Fujiwara, S. Kawabata, A. Amano, and S. Hamada. 2003. Infection of Streptococcus pyogenes induces the receptor activator of NF-κB ligand expression in mouse osteoblastic cells. Infect. Immun. 71:948-955.
24. Puliti, M., F. Bistoni, C. von Hunolstein, G. Orefici, and L. Tissi. 2001. Severity of group B streptococcal arthritis in selected strains of laboratory mice. Infect. Immun. 69:551-555.
25. Romas, E., M. T. Gillespie, and T. J. Martin. 2002. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340-346.
26. Romas, E., N. A. Sims, D. K. Hards, M. Lindsay, J. W. M. Quinn, P. F. J. Ryan, C. R. Dunstan, T. J. Martin, and M. T. Gillespie. 2002. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am. J. Pathol. 161:1419-1427.
27. Schattner, A., and K. L. Vosti. 1998. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore) 77:122-139.
28. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelly, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
29. Stefnelli, N., H. Klotz, A. Engel, and P. Bauer. 1985. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J. Cancer Res. Clin. Oncol. 109:55-59.
30. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev. 20:345-357.
31. Takayanagi, H., H. Iizuka, T. Juji, T. Nakagawa, A. Yamamoto, T. Miyazaki, Y. Koshihara, H. Oda, K. Nakamura, and S. Tanaka. 2000. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43:259-269.
32. Tanahashi, M., J. Koike, N. Kawabe, and T. Nakadate-Matsushita. 1998. Inhibitory effect of TRK-530 on inflammatory cytokines in bone marrow of rats with adjuvant arthritis. Pharmacology 56:237-241.
33. Tarkowski, A., L. V. Collins, I. Gjertsson, O. H. Hultgren, I. M. Jonsson, E. Sakiniene, and M. Verdrengh. 2001. Model systems: modeling human staphylococcal arthritis and sepsis in the mouse. Trends Microbiol. 9:321-326.
34. Tissi, L., P. Marconi, P. Mosci, L. Merletti, P. Cornacchione, E. Rosati, S. Recchia, C. von Hunolstein, and G. Orefici. 1990. Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Infect. Immun. 58:3093-3100.
35. Tissi, L., M. Puliti, R. Barluzzi, G. Orefici, C. von Hunolstein, and F. Bistoni. 1999. Role of tumor necrosis factor alpha, interleukin-1β, and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect. Immun. 67:4545-4550.
36. van der Heijden, I. M., B. Wilbrink, I. Tchetverikov, I. A. Schrijver, L. M. Schouls, M. P. Hazenberg, F. C. Breedveld, and P. P. Tak. 2000. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 43:593-598.
37. Yamaguchi, K., M. Kinosaki, M. Goto, F. Kobayashi, E. Tsuda, T. Morinaga, and K. Higashio. 1998. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J. Biol. Chem. 273:5117-5123.